These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34729063)

  • 1. Trends of human brucellosis in Central Iran (2010-2018).
    Khalilian MS; Ramazanpour J; Hosseini SM; Narrei S; Zeinalian M
    J Res Med Sci; 2021; 26():55. PubMed ID: 34729063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological features of human brucellosis in central Iran, 2006-2011.
    Zeinalian Dastjerdi M; Fadaei Nobari R; Ramazanpour J
    Public Health; 2012 Dec; 126(12):1058-62. PubMed ID: 22884862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the Epidemiology of Brucellosis Cases in Iran during the Last Decade.
    Zeinali M; Doosti S; Amiri B; Gouya MM; Godwin GN
    Iran J Public Health; 2022 Dec; 51(12):2791-2798. PubMed ID: 36742247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing Patterns in Epidemiology of Brucellosis in the South of Iran (2015-2020): Based on Cochrane-Armitage Trend Test.
    Delam H; Keshtkaran Z; Rezaei B; Soufi O; Bazrafshan MR
    Ann Glob Health; 2022; 88(1):11. PubMed ID: 35223430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of human brucellosis in Nahavand county, Hamadan Province, western Iran: an 8-year (2010-2017) registry-based analysis.
    Khazaei S; Solgi M; Goodarzi S; Khazaei L; Salehi I; Jenabi E
    Asian Biomed (Res Rev News); 2020 Aug; 14(4):151-158. PubMed ID: 37551387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological Characteristics and Trend in the Incidence of Human Brucellosis in Iran from 2009 to 2017.
    Norouzinezhad F; Erfani H; Norouzinejad A; Ghaffari F; Kaveh F
    J Res Health Sci; 2021 Dec; 21(4):e00535. PubMed ID: 36511231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological, laboratory, diagnostic and public health aspects of human brucellosis in western Iran.
    Kassiri H; Amani H; Lotfi M
    Asian Pac J Trop Biomed; 2013 Aug; 3(8):589-94; discussion 593-4. PubMed ID: 23905014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time series and trend analysis of brucellosis in Oskou county, East Azerbaijan: 2007-2016.
    Rafiemanesh H; Alimohamadi Y; Hashemi Aghdam SR; Safarzadeh A; Shokri A; Zemestani A
    Health Promot Perspect; 2019; 9(4):285-290. PubMed ID: 31777708
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence and Risk Factors of Brucellosis in Kermanshah Province, Iran During 2010-2014.
    Rajabi J; Hamidi-Farahani R; Mansouri F; Soleiman-Meigooni S
    Infect Disord Drug Targets; 2020; 20(2):203-207. PubMed ID: 30539704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial Distribution and Epidemiological Factors of Brucellosis in Ardabil Province, Iran.
    Jafarzadeh M; Habibzadeh S; Moradi-Asl E; Mohamadshahi J; Abishvand J; Nakhostin B
    Health Serv Res Manag Epidemiol; 2023; 10():23333928231211412. PubMed ID: 37954480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trend Analysis and Affecting Components of Human Brucellosis Incidence During 2006 to 2016.
    Marvi A; Asadi-Aliabadi M; Darabi M; Abedi G; Siamian H; Rostami-Maskopaee F
    Med Arch; 2018 Feb; 72(1):17-21. PubMed ID: 29416212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological, Risk Factors, Clinical, and Laboratory Features of Brucellosis in the Southwest of Iran within 2009-2015.
    Nabavi M; Hatami H; Jamaliarand H
    Int J Prev Med; 2019; 10():108. PubMed ID: 31360355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal analysis of brucellosis incidence in Iran from 2011 to 2014 using GIS.
    Pakzad R; Pakzad I; Safiri S; Shirzadi MR; Mohammadpour M; Behroozi A; Sullman MJM; Janati A
    Int J Infect Dis; 2018 Feb; 67():129-136. PubMed ID: 29122689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological Trend of Cutaneous Leishmaniasis in an Endemic Focus Disease During 2009-2016, Central Iran.
    Moein D; Masoud D; Mahmood N; Abbas D
    Turkiye Parazitol Derg; 2019 Jun; 43(2):55-59. PubMed ID: 31204455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial and spatio-temporal analysis of human brucellosis in Iran.
    Mollalo A; Alimohammadi A; Khoshabi M
    Trans R Soc Trop Med Hyg; 2014 Nov; 108(11):721-8. PubMed ID: 25157126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiologic, clinical and laboratory findings of patients with brucellosis in Hamadan, west of Iran.
    Eini P; Keramat F; Hasanzadehhoseinabadi M
    J Res Health Sci; 2012 Dec; 12(2):105-8. PubMed ID: 23241521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of human brucellosis in Isfahan, Iran.
    Sabbaghian H; Nadim A
    J Hyg (Lond); 1974 Oct; 73(2):221-8. PubMed ID: 4529097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological Features of Human Brucellosis in Iran (2011-2018) and Prediction of Brucellosis with Data-Mining Models.
    Bagheri H; Tapak L; Karami M; Amiri B; Cheraghi Z
    J Res Health Sci; 2019 Dec; 19(4):e00462. PubMed ID: 32291361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological characteristics of human brucellosis in Hamadan Province during 2009-2015: results from the National Notifiable Diseases Surveillance System.
    Nematollahi S; Ayubi E; Karami M; Khazaei S; Shojaeian M; Zamani R; Mansori K; Gholamaliee B
    Int J Infect Dis; 2017 Aug; 61():56-61. PubMed ID: 28602765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of Brucellosis among General Population in Famenin City, Western Iran in 2016: The Famenin Brucellosis Cohort Study.
    Keramat F; Karami M; Alikhani MY; Bashirian S; Moghimbeigi A; Hashemi SH; Mamani M; Shivapoor Z; Bosilkovski M; Adabi M
    Arch Iran Med; 2020 Nov; 23(11):749-756. PubMed ID: 33220691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.